Organisation paid for research Program year 2023 Source: CMS Open Payments

APF Research, LLC

Neither a doctor nor a teaching hospital

Research payments

$143,303

14 payments

Through program year 2023, APF Research, LLC is reported as receiving $143,303 in research payments, across 14 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2023	Research	$48,165	4
2022	Research	$10,830	2
2021	Research	$71,150	4
2019	Research	$13,158	4

Breakdown

Who paid Research payments · program years 2019–2023

Perrigo Company plc $73,650 5 payments
Journey Medical Corporation $58,995 6 payments
Vanda Pharmaceuticals Inc. $10,658 3 payments

Studies the money was for Research payments · program years 2019–2023

Bioequivalence study $71,150 4 payments
Dfd-29-Cd-004 $40,800 4 payments
Dfd-29-Cd-005 $18,195 2 payments
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Assess the Efficacy of Tradipitant in Relieving Symptoms of Gastroparesis $8,070 2 payments
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis $2,588 1 payment
Bioequivalence study between Perrigo's product and mupirocin calcium cream $2,500 1 payment

What the money was spent on Research payments · program years 2019–2023

Patient care $10,830 2 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.